BIOT

Biotech Acquisition Company [BIOT] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

BIOT Stock Summary

In the News

BIOT Financial details

Company Rating
-
Market Cap
0
Income
13.24M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
12.8
Forward P/E
-
PEG
-
P/S
-
P/B
-22.24
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
0.03
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
1.11
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-86.24%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
10%
ROE
-172%
ROC
-0.01%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
8.3-10.41
52W High
+1.5%
52W Low
+26.88%
RSI
-
Rel Volume
0.42
Avg Volume
103.99K
Volume
44.12K
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-0.78%
-
-
-
-
Beta
-
-
-
Volatility
0.03%, 0.03%
Prev Close
0%
Price
10.15
Change
-0.39%

Something similar

Top by Market Cap
FXAIX
GOOG
CMC.DE
ABEC.DE
APC.DE
Same Sector
UET0.DE
600909.SS
ZSP.TO
GNACU
PCK
Check Those
RET.BR
8079.HK
8002.T
4284.T
SHECY
Similar Market Cap
HIX.TO
KEMX
005880.KS
SML.NZ
600019.SS

Company Profile

Financial Services Shell Companies
  • Volume Average 103.99K
  • CEO Dr. Michael Shleifer Ph.D.
  • Headquarters New York,NY,US
  • IPO Date 2021-03-18

Biotech Acquisition Company does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.